Dow Pharmaceutical Sciences Inc., has declared that Food and Drug Administration (FDA) has approved its ZIANA (TM) Gel a topical application cream for acne vulgaris. The product would be available by the end of the year 2006.

Product Review
a. The gel is the first and only combination of clindamycin and tretinoin both used separately for acne vulgaris.
b. First and only approved acne product to combine antibiotic and retinoid
c. It is alcohol free aqueous base with convenience of once-a-day application.
d. ZIANA (TM) Gel is available in 30 gram and 60 gram tubes.
e. Can be used for topical application in patients, 12-year old or above.
f. Nasopharyngitis, pharyngolaryngeal pain, dry skin, sinusitis and cough are the side effects of ZIANA (TM) (found during trials)
g. During the usage of ZIANA (TM) Gel, exposure to sunlight and even sunlamps should be avoided.
h. More information about ZIANA (TM) Gell is found at